Biodelivery Sciences International reported $77.66M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.07M 1.88M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Agile Therapeutics AGRX:US $ 9.57M 2.07M
Alimera Sciences ALIM:US $ 11.4M 1.09M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Cara Therapeutics CARA:US $ 15.53M 358K
Cti Biopharma CTIC:US $ 62.34M 46.55M
Daiichi Sankyo 4568:JP Y 336046M 3275M
Depomed DEPO:US $ 100.48M 16.43M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Knight Therapeutics Inc GUD:CN C$ 132.55M 14.78M
Lannett LCI:US $ 112.28M 21.81M
Mannkind MNKD:US $ 50.03M 10.4M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Redhill Biopharma RDHL:US $ 81.66M 2.49M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Teva Pharmaceutical TEVA:IT 11.82B 866M